2m 2m 2m 2m 2m 2m 2m
NURIX THERAPEUTC-RG (NRIX)
NASDAQ
$23.01-$0.34 (-1.44%)
Price as of Oct 02, 2026 4:42 PM EDT- $2.4BMarket Cap
- 157.05%1-Year Change
- BiotechnologyIndustry
NURIX THERAPEUTC-RG (NRIX)
$23.01-$0.34 (-1.44%)
NRIX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $23.34 | ||
Change | -$0.37 (-1.56%) | ||
Open | $23.60 | ||
High | $23.98 | ||
Low | $23.21 | ||
Previous Close | $23.71 | ||
Volume | 1,334,902 | ||
30-Day Average Volume | 1,562,007 | ||
1-Week Change | -1.31% | ||
1-Month Change | -10.37% | ||
1-Year Change | 157.05% | ||
3-Year Change | 196.95% | ||
5-Year Change | -25.29% | ||
Fundamentals | |||
Shares Outstanding | 103.8M | ||
Total Assets | $535.5M | ||
Market Cap | $2.4B | ||
Enterprise Value | $2.4B | ||
Period: QTR TTM FY | |||
Revenue | $9.0M | ||
Net Income | -$89.5M | ||
Free Cash Flow | -$98.5M | ||
EBIT | -$89.8M | ||
EBITDA | -$87.6M | ||
Net Working Capital | $384.5M | ||
EPS | -$0.81 | ||
Enterprise Value/EBITDA | -27 | ||
Enterprise Value/Revenue | 260 | ||
P/B | 6 | ||
P/E | -29 | ||
PEG | 11 | ||
Price/Free Cash Flow | -25 | ||
Price/Operating Cash Flow | -25 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue